Global Neurology Academy

The Global Neurology Academy (GNA) series offers certified education modules and video interviews from leading MS experts from across the globe as they address topics such as induction therapy in relapsing-remitting multiple sclerosis; No Evidence of Disease Activity (NEDA) concept; how different agents used in MS management may be utilized in induction therapy; appreciation of how reductions in end-organ damage impact patient quality-of-life; mechanisms of action of the classical as well as emergent agents; key issues associated with making the correct differential diagnosis of multiple sclerosis, in addition to how best to incorporate prognostic indicators into clinical decision-making; current and emergent novel oral agents in MS management; and diagnostic strategies and identifying predictors of outcome.

For more information about GNA, visit www.globalneurologyacademy.org.

403

LikeLikedUnlike

Episodes 136-150 of 183

Personalized Care for Diverse MS Populations: Special Populations Equal Special Care
MinuteCE®
Personalized Care for Diverse MS Populations: Special Populations Equal Special Care
- Mark S. Freedman, MSc, MD, FANA, FAAN, CSPQ, FRCPC
  Peer
- Ahmed Z. Obeidat, MD, PhD
  Peer
1.00 program credits
MS Cognitive Insights: Management, Diagnostic, and Treatment Strategies
MinuteCE®
MS Cognitive Insights: Management, Diagnostic, and Treatment Strategies
- Mark S. Freedman, MSc, MD, FANA, FAAN, CSPQ, FRCPC
  Peer
- Ahmed Z. Obeidat, MD, PhD
  Peer
1.00 program credits
Brain Health in MS: A Comprehensive Approach
MinuteCE®
Brain Health in MS: A Comprehensive Approach
- Mark S. Freedman, MSc, MD, FANA, FAAN, CSPQ, FRCPC
  Peer
- Ahmed Z. Obeidat, MD, PhD
  Peer
1.00 program credits
PROs in MS: A New Era of Patient-Centric Care
MinuteCE®
PROs in MS: A New Era of Patient-Centric Care
- Mark S. Freedman, MSc, MD, FANA, FAAN, CSPQ, FRCPC
  Peer
- Ahmed Z. Obeidat, MD, PhD
  Peer
1.00 program credits
Schizophrenia Care: Improving Social Cognition and Motivation
On the Frontlines of Schizophrenia
Schizophrenia Care: Improving Social Cognition and Motivation
- Michael Green, PhD
  Peer
The Evolving gMG Treatment Landscape
NeuroFrontiers
The Evolving gMG Treatment Landscape
- Henry Kaminski, MD
  Peer
advertisement
Examining Schizophrenia Risk: The Influence of B12 Levels in Early Pregnancy
NeuroFrontiers
Examining Schizophrenia Risk: The Influence of B12 Levels in Early Pregnancy
Unseen Struggles: Impacts of Homelessness on Women with Schizophrenia
NeuroFrontiers
Unseen Struggles: Impacts of Homelessness on Women with Schizophrenia
NKX019: A Potential New Frontier in Generalized Myasthenia Gravis Therapy
NeuroFrontiers
NKX019: A Potential New Frontier in Generalized Myasthenia Gravis Therapy
Beyond Amyloid and Tau: A Multimarker Approach to Alzheimer's Detection
NeuroFrontiers
Beyond Amyloid and Tau: A Multimarker Approach to Alzheimer's Detection
- Thomas Karikari, PhD
  Peer
Debunking Misconceptions Regarding the Revised Alzheimer’s Diagnostic Criteria
NeuroFrontiers
Debunking Misconceptions Regarding the Revised Alzheimer’s Diagnostic Criteria
- Clifford Jack Jr., MD
  Peer
Reviewing the Revised Alzheimer’s Diagnostic Criteria: The Role of Biomarkers
NeuroFrontiers
Reviewing the Revised Alzheimer’s Diagnostic Criteria: The Role of Biomarkers
- Clifford Jack Jr., MD
  Peer
advertisement
Mind Matters: Psychiatric Comorbidity in the Prodromal Phase of MS
NeuroFrontiers
Mind Matters: Psychiatric Comorbidity in the Prodromal Phase of MS
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Anibal Chertcoff, MD
  Peer
Diagnosing Suspected MS: A Review of the Updated Guidelines
NeuroFrontiers
Diagnosing Suspected MS: A Review of the Updated Guidelines
- Andrew Wilner, MD, FACP, FAAN
  Peer
- Eoin Flanagan, MB, BCh
  Peer
Advances in Temporal Lobe Epilepsy Research
NeuroFrontiers
Advances in Temporal Lobe Epilepsy Research
- Andrew Wilner, MD, Author of "The Locum Life: A Physician's Guide to Locum Tenens"
  Peer
- Sanjay Kumar, PhD
  Peer